Pilsicainide is a secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker that is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan. Among its listed roles, it functions as a anti-arrhythmia drug and a sodium channel blocker. It is a secondary carboxamide and an organic heterobicyclic compound. Its therapeutic use is listed as antiarrhythmics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pilsicainida and Pilsicainidum. Its PubChem CID is 4820.
Pilsicainide
| CAS No | 88069-67-4 |
|---|---|
| Molecular Formula | C8H14N4O2 |
| Molecular Weight | 272.40 g/mol |
| Synonyms | 1,3,4,6-tetramethyl-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pilsicainide is a secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid.
The listed CAS number is 88069-67-4.
The listed molecular formula is C8H14N4O2.
The listed molecular weight is 272.40 g/mol.
1,3,4,6-tetramethyl-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione.
The source lists Pilsicainida and Pilsicainidum.